radiotherapeutics

ra·di·o·ther·a·peu·tics

(rā'dē-ō-ther'ă-pyū'tiks),
The study and use of radiotherapeutic agents.

ra·di·o·ther·a·peu·tics

(rā'dē-ō-thār'ă-pyū'tiks)
The study and use of radiotherapeutic agents.

radiotherapeutics

(rā″dē-ō-thĕr″ă-pū′tĭks)
1. Radiotherapy.
2. The study of radiotherapeutic agents.
References in periodicals archive ?
com)-- MEDraysintell releases a new report covering the most promising radiopharmaceuticals (radiodiagnostics, radiotherapeutics and radiotheranostics) currently in clinical stage development which have the highest chances to reach the market by 2024-2026.
M2 PHARMA-September 26, 2017-Fusion Pharmaceuticals Raises Additional USD 21m Capital for Total of USD 46m for Development of Targeted Alpha Radiotherapeutics
Previous studies have demonstrated that hematologic malignancies are highly sensitive to radiotherapeutics.
We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments.
This important Azedra trial in children with neuroblastoma underscores our full commitment to develop small molecule, targeted radiotherapeutics that address significant unmet needs in cancers affecting both adults and children," said David S.
This is likely to lead to a new generation of molecular imaging pharmaceuticals and targeted radiotherapeutics with enhanced radiochemical stability.
RadioTherapeutics Corporation (Sunnyvale, CA; 408-745-3200) announced that it has joined with Scimed Life Systems, Inc.
We had an absolutely terrific and successful working partnership when we served together previously at RadioTherapeutics, and we look forward to more of the same.
Radiotherapeutics will soon become part of their portfolio at the same level if not more efficient than chemotherapies.
M2 PHARMA-February 24, 2017-Fusion Pharmaceuticals Launches; Will Develop Targeted Radiotherapeutics as Cancer Treatments
RadioTherapeutics Corporation (Sunnyvale, CA; 408-745-3200) announced the issuance of three key patents covering the full breadth of its radiofrequency ablation technology for destroying diseased or cancerous tissue.